Capricor Therapeutics Inc
General ticker "CAPR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $513.2M
Capricor Therapeutics Inc follows the US Stock Market performance with the rate: 40.9%.
Estimated limits based on current volatility of 3.2%: low 13.11$, high 13.98$
Factors to consider:
- Current price 71.3% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.96$, 8.18$]
- 2024-12-30 to 2025-12-30 estimated range: [3.40$, 8.95$]
Financial Metrics affecting the CAPR estimates:
- Negative: Non-GAAP EPS, $ of -0.87 <= 0.10
- Negative: Operating profit margin, % of -48.88 <= 1.03
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Operating cash flow per share per price, % of -20.36 <= 2.35
Short-term CAPR quotes
Long-term CAPR plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.24MM | $2.55MM | $25.18MM |
| Operating Expenses | $21.18MM | $32.25MM | $49.26MM |
| Operating Income | $-20.94MM | $-29.70MM | $-24.08MM |
| Non-Operating Income | $0.28MM | $0.68MM | $1.79MM |
| R&D Expense | $13.57MM | $21.82MM | $36.45MM |
| Income(Loss) | $-20.66MM | $-29.02MM | $-22.29MM |
| Profit(Loss) | $-20.66MM | $-29.02MM | $-22.29MM |
| Stockholders Equity | $31.37MM | $11.79MM | $22.60MM |
| Inventory | $0.00MM | $0.00MM | $0.00MM |
| Assets | $41.33MM | $50.09MM | $58.73MM |
| Operating Cash Flow | $-16.81MM | $4.92MM | $-25.60MM |
| Capital expenditure | $1.20MM | $3.36MM | $2.05MM |
| Investing Cash Flow | $-1.20MM | $-35.07MM | $5.11MM |
| Financing Cash Flow | $20.23MM | $4.87MM | $25.58MM |
| Earnings Per Share* | $-0.84 | $-1.18 | $-0.83 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.